C2 Project - The effect of perinatal stress on the later outcome in preterm babies
From 01-10-2015 to 30-09-2019
Description
About 8% of all births in Belgium are preterm, which makes it an important public health issue. Advances in neonatal care, such as the use of antenatal corticosteroids, surfactant administration and assisted ventilation have improved survival rates. However, very preterm infants remain at risk for adverse health outcome and neurodevelopmental disability.Cerebral palsy , serious motor delays , cognitive impairments, learning deficits and behavioral problems (ADHD, autism) have been observed in very preterm infants. Furthermore, emotional problems have been reported with symptoms such as shyness, unassertiveness, social maladaptation and anxiety . As these maladaptive outcomes have a severe effect on these children’s quality of life and have a huge economic impact on society ,the current proposal aims at improving our understanding about a factor that has been proposed as crucial: exposure to perinatal distress.
Team
- Sabine Van Huffel, Co-promoter
- Els Ortibus, Co-promoter (External)
- Guy Bosmans, Co-promoter (External)
- Lieven Lagae, Co-promoter (External)
- Stephan Claes, Co-promoter (External)
- Johan Verhaeghe, Co-promoter (External)
- Gunnar Naulaers, Promoter (External)
Financing
Funding: KU Leuven - Internal Funding KU Leuven
Program/Grant Type: C2 - KU Leuven Category 2 Funding
Events
2/09/2024:
PhD defense - Martijn Oldenhof
Machine Learning for Advanced Chemical Analysis and Structure Recognition in Drug Discovery
3/09/2024:
Meet the Jury Igor Tetko on Advanced Machine Learning in Drug Discovery
12/09/2024:
Multimodal analysis of cell-free DNA for sensitive cancer detection in low-coverage and low-sample settings
Seminar by Antoine Passemiers
News
STADIUS Alumni Herman Verrelst – new CEO of Biocartis
08 June 2017
Herman Verrelst, the founder of KU Leuven spin-off Cartagenia, who has been working in Silicon Valley, US for the last few years will be returning to Belgium to follow the steps of Rudi Pauwels as CEO of the Belgian diagnostic company, Biocartis.
Supporting healthcare policymaking via machine learning – batteries included!
29 May 2017
STADIUS takes the lead in the data analytics efforts in an ambitious European Project MIDAS.
Marc Claesen gives an interview about his PhD for the magazine of the Faculty of Engineering Sciences "Geniaal"
10 February 2017
Did you know that in Belgium approximately one third of type 2 diabetes patients are unaware of their condition?
Joos Vandewalle is nieuwe voorzitter KVAB
09 October 2016
Op 5 oktober 2016 heeft de Algemene Vergadering van de Academie KVAB Joos Vandewalle verkozen tot voorzitter van de KVAB.